This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Menzaghi, C. Articles by Trischitta, V. Search for Related Content PubMed PubMed Citation Articles by Menzaghi, C. Articles by Trischitta, V. Related Collections Metabolism

Heritability of Serum Resistin and Its Genetic Correlation with Insulin Resistance-Related Features in Nondiabetic Caucasians

Research Unit of Diabetology and Endocrinology (C.M., A.C., L.S., S.D.C., V.T.), Scientific Institute Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo (FG), Italy; Research Division (R.T., A.D.), Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115; and Department of Clinical Sciences (V.T.), University "La Sapienza", 00161 Rome, Italy

Address all correspondence and requests for reprints to: Claudia Menzaghi, Ph.D., Research Unit of Diabetology and Endocrinology, Scientific Institute "Casa Sollievo della Sofferenza", 71013 San Giovanni Rotondo (FG) Italy. E-mail: c.menzaghi{at}operapadrepio.it; or Vincenzo Trischitta, M.D., Department of Clinical Sciences, University "La Sapienza", Rome, Italy. E-mail: vincenzo.trischitta{at}uniroma1.it

Context: Serum levels of resistin are believed to modulate insulin resistance in humans.

Objective: The aim of this study was to investigate whether serum resistin levels are genetically controlled and whether this control is shared with other insulin resistance traits.

Design and Methods: The study cohort included 264 nondiabetic probands, Caucasian from Italy, and their 473 adult family members. Phenotypic characterization included anthropometric variables, blood pressure, fasting glucose and insulin, lipid profile, and resistin levels. Genotypes were determined at position g.–420CG (rs1862513), IVS2+181GA (rs3745367), and GAT_(n) polymorphisms of the resistin (RETN) gene.

Results: In the 264 unrelated probands, resistin levels were significantly (P < 0.01) correlated with adiposity, blood pressure, C-reactive protein, and the metabolic syndrome score. In a variance component analysis of the 264 probands and their 473 relatives, about 70% of the observed variation of serum resistin levels was heritable (P < 0.0001). A small, but significant (P = 0.004) proportion of this variance was explained by the GA variation at position IVS2+181 of the RETN gene. Significant genetic correlations (P < 0.05) were observed between resistin and body mass index (_g = 0.30), waist circumference (_g = 0.32), the insulin resistance index HOMA_IR (_g = 0.28), and the metabolic syndrome score (_g = 0.35).

Conclusions: These data indicate that serum resistin is highly heritable and has some common genetic background with traits related to insulin resistance, reinforcing the hypothesis that this adipokine may play a pathogenic role in insulin resistance-related abnormalities, including type 2 diabetes and cardiovascular disease.

This article has been cited by other articles:

				S. Bacci, R. Di Paola, C. Menzaghi, P. Di Fulvio, S. Di Silvestre, F. Pellegrini, R. Baratta, A. Marucci, S. Mastroianno, G. Fini, et al. ENPP1 Q121 Variant, Increased Pulse Pressure and Reduced Insulin Signaling, and Nitric Oxide Synthase Activity in Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1678 - 1683. [Abstract] [Full Text] [PDF]

				M.-F. Hivert, A. K. Manning, J. B. McAteer, J. Dupuis, C. S. Fox, L. A. Cupples, J. B. Meigs, and J. C. Florez Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring Study Diabetes, March 1, 2009; 58(3): 750 - 756. [Abstract] [Full Text] [PDF]

				M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel The Metabolic Syndrome Endocr. Rev., December 1, 2008; 29(7): 777 - 822. [Abstract] [Full Text] [PDF]

				R. S. Ahima and M. A. Lazar Adipokines and the Peripheral and Neural Control of Energy Balance Mol. Endocrinol., May 1, 2008; 22(5): 1023 - 1031. [Abstract] [Full Text] [PDF]

				J. Golledge, P. Clancy, K. Jamrozik, and P. E. Norman Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study Circulation, November 13, 2007; 116(20): 2275 - 2279. [Abstract] [Full Text] [PDF]

				E Krusinova, M Klementova, J Kopecky, P Wohl, L Kazdova, P Mlejnek, M Pravenec, M Hill, and T Pelikanova Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects Eur. J. Endocrinol., October 1, 2007; 157(4): 443 - 449. [Abstract] [Full Text] [PDF]

				I Pantsulaia, G Livshits, S Trofimov, and E Kobyliansky Genetic and environmental determinants of circulating resistin level in a community-based sample Eur. J. Endocrinol., January 1, 2007; 156(1): 129 - 135. [Abstract] [Full Text] [PDF]